Frank J. Lane
Directeur/Bestuurslid bij ALBERT LABS INTERNATIONAL CORP.
Actieve functies van Frank J. Lane
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CFN ENTERPRISES INC. | Corporate Officer/Principal | 01-06-2019 | - |
| ALBERT LABS INTERNATIONAL CORP. | Directeur/Bestuurslid | - | - |
| Cfn Media | Oprichter | 01-01-2013 | - |
| President | 01-06-2019 | - | |
Albert Labs, Inc.
 Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Directeur/Bestuurslid | - | - |
Loopbaan van Frank J. Lane
Opleiding van Frank J. Lane
| Seattle University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 2 |
| Canada | 2 |
Operationeel
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Founder | 1 |
Sectoraal
| Technology Services | 2 |
| Consumer Services | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CFN ENTERPRISES INC. | Technology Services |
| ALBERT LABS INTERNATIONAL CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Cfn Media | |
Albert Labs, Inc.
Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Health Services |
- Beurs
- Insiders
- Frank J. Lane
- Ervaring
